Yahya Khan

Yahya Khan

Auto-generated profile, based on publicly available information

Yahya Khan

Institute of kidney Disease, Peshawar, Pakistan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Nursing in Critical Care
Verified
Journal Article
Closed access
KRKhalid Rashid
Khalid Rashid
FAFarrukh Ansar
Farrukh Ansar
YKYahya Khan
Yahya Khan
NRNabhan Rashad
Nabhan Rashad
HRHafeez Rehman
Hafeez Rehman
MWMuhammad Waheed
Muhammad Waheed

30 January 2024 in Health Science Reports
Verified
Journal Article
Open access
KRKhalid Rashid
Khalid Rashid
MWMuhammad Aamir Waheed
Muhammad Aamir Waheed
FAFarrukh Ansar
Farrukh Ansar
AMAbdelrahman M. Makram
Abdelrahman M. Makram
AHAhmedyar Hasan
Ahmedyar Hasan
AEAbdelnaser Elzouki
Abdelnaser Elzouki
Introduction: Out‐of‐hospital cardiac arrest (OHCA) is defined as the loss of functional mechanical activity of the heart in association with an absence of systemic circulation, occurring outside of a hospital. Immediate coronary angiography (CAG) with percutaneous coronary intervention is recommended for OHCA with ST‐elevation. We aimed to evaluate the effect of early CAG on mortality and neurological outcomes in OHCA patients without ST‐elevation. Methods: This meta‐analysis and systemic review was conducted as per principles of Preferred Reporting Items for Systematic Reviews and Meta‐analysis (PRISMA) group. A protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO, Ref No. = CRD42022327833). A total of 674 studies were retrieved after scanning several databases (PubMed Central, EMBASE, Medline, and Cochrane Central Register of Controlled Trials). Results: A total of 18 studies were selected for the final analysis, including 6 randomized control trials and 12 observational studies. Statistically, there was no significant difference in primary outcome, i.e., mortality, between early and delayed CAG. In terms of the grade of neurological recovery as a secondary outcome, early and delayed CAG groups also showed no statistically significant difference. Conclusion: Early CAG has no survival benefits in patients with no ST elevations on ECG after OHCA.

7 July 2026 in Open Medicine
Verified
Journal Article
Open access
KRKhalid Rashid
Khalid Rashid
AHAhmedyar Hasan
Ahmedyar Hasan
MJMustafa Javaid
Mustafa Javaid
FAFarrukh Ansar
Farrukh Ansar
YKYahya Khan
Yahya Khan
MWMuhammad Aamir Waheed
Muhammad Aamir Waheed
To compare the mortality and clinical outcomes of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) in patients with low- or intermediate-risk symptomatic severe aortic stenosis through an updated systematic review and meta-analysis of randomized controlled trials. This systematic review was performed using PubMed, Medline, Embase, and Cochrane databases for RCTS between 2017 and 2024 which evaluated mortality outcomes in patients with low to intermediate risk AS who received TAVI vs. SAVR. Relative risks (RRs) with 95 % confidence intervals (CIs) were pooled using random effects models. TAVI showed a numerically lower but statistically insignificant mortality risk compared to SAVR (RR: 0.88, 95 % CI: 0.62–1.25, p=0.49). TAVI was associated with a higher risk of PPM insertion (RR: 2.19, 95 % CI: 1.55–3.16, p<0.001, i2: 80 %), aortic valve re-intervention (RR: 2.51, 95 % CI: 1.40–4.51, p<0.001; I2=0 %), new-onset bundle branch block (RR: 2.10, 95 % CI: 1.21–3.67, p<0.01; I2=84 %), and vascular site complications (RR: 4.77, 95 % CI: 2.11–10.81, p<0.001; I2=62 %). Atrial fibrillation incidence was lower with TAVI (RR: 0.29, 95 % CI: 0.23–0.38, p<0.001; I2=73). There was no significant difference in the rates of post-procedural myocardial infarction, stroke and endocarditis between TAVI and SAVR. TAVI has mortality outcomes comparable to SAVR in low to intermediate risk patients. TAVI offers advantages in atrial fibrillation reduction, but is associated with increased risk of PPM insertion, vascular complications, new-onset bundle branch block, aortic valve re-intervention. Individualized treatment decisions remain important for optimizing outcomes in low to intermediate risk patients. CRD42024547882.